Close

Analyst Ratings for Protalix BioTherapeutics (PLX)

PLX Rating Summary

PLX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PLX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $10.00 (+747.5%) * Over Last 12-Mos
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/23/2015 Jefferies
» Updated 10/19/2017
N/A Upgrade Buy
(N/A)
2.10
(1.80)
2.08
(1.18)
-43.27% Details
10/21/2013 JPMorgan N/A New Coverage Overweight
(N/A)
7.00
(N/A)
4.43
(1.18)
-73.36% Details